These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
235 related items for PubMed ID: 9216635
21. Sequence-specific enhancer binding protein is responsible for the differential expression of ERT/ESX/ELF-3/ESE-1/jen gene in human gastric cancer cell lines: Implication for the loss of TGF-beta type II receptor expression. Park SH, Kim YS, Park BK, Hougaard S, Kim SJ. Oncogene; 2001 Mar 08; 20(10):1235-45. PubMed ID: 11313868 [Abstract] [Full Text] [Related]
24. Alternative splicing of TGF-betas and their high-affinity receptors T beta RI, T beta RII and T beta RIII (betaglycan) reveal new variants in human prostatic cells. Konrad L, Scheiber JA, Völck-Badouin E, Keilani MM, Laible L, Brandt H, Schmidt A, Aumüller G, Hofmann R. BMC Genomics; 2007 Sep 11; 8():318. PubMed ID: 17845732 [Abstract] [Full Text] [Related]
27. Differential control of expression of type I and type II receptors of transforming growth factor-beta in colon carcinoma cells. Periyasamy S, Sun L, Gentry LE, Brattain MG. J Cell Physiol; 1996 Sep 11; 168(3):711-20. PubMed ID: 8816926 [Abstract] [Full Text] [Related]
28. The expression levels and the differential expression of transforming growth factor-beta receptors in dermatofibroma and dermatofibrosarcoma protuberans. Kubo M, Ihn H, Yamane K, Tamaki K. Br J Dermatol; 2006 May 11; 154(5):919-25. PubMed ID: 16634896 [Abstract] [Full Text] [Related]
29. The expression of TGF-beta receptors in human atherosclerosis: evidence for acquired resistance to apoptosis due to receptor imbalance. McCaffrey TA, Du B, Fu C, Bray PJ, Sanborn TA, Deutsch E, Tarazona N, Shaknovitch A, Newman G, Patterson C, Bush HL. J Mol Cell Cardiol; 1999 Sep 11; 31(9):1627-42. PubMed ID: 10471347 [Abstract] [Full Text] [Related]
30. Role of transforming growth factor-beta in transdifferentiation and fibrosis of lens epithelial cells. Lee EH, Joo CK. Invest Ophthalmol Vis Sci; 1999 Aug 11; 40(9):2025-32. PubMed ID: 10440257 [Abstract] [Full Text] [Related]
32. Targets of transcriptional regulation by two distinct type I receptors for transforming growth factor-beta in human umbilical vein endothelial cells. Ota T, Fujii M, Sugizaki T, Ishii M, Miyazawa K, Aburatani H, Miyazono K. J Cell Physiol; 2002 Dec 11; 193(3):299-318. PubMed ID: 12384983 [Abstract] [Full Text] [Related]
33. Mechanism of induction of transforming growth factor-beta type II receptor gene expression by v-Src in murine myeloid cells. Park SH, Birchenall-Roberts MC, Yi Y, Lee BI, Lee DK, Bertolette DC, Fu T, Ruscetti F, Kim SJ. Cell Growth Differ; 2001 Jan 11; 12(1):9-18. PubMed ID: 11205746 [Abstract] [Full Text] [Related]
34. Effect of Nma on growth inhibition by TGF-betaa in human gastric carcinoma cell lines. Sasaki T, Sasahira T, Shimura H, Ikeda S, Kuniyasu H. Oncol Rep; 2004 Jun 11; 11(6):1219-23. PubMed ID: 15138559 [Abstract] [Full Text] [Related]
36. Farnesyltransferase inhibitor (L-744,832) restores TGF-beta type II receptor expression and enhances radiation sensitivity in K-ras mutant pancreatic cancer cell line MIA PaCa-2. Alcock RA, Dey S, Chendil D, Inayat MS, Mohiuddin M, Hartman G, Chatfield LK, Gallicchio VS, Ahmed MM. Oncogene; 2002 Nov 07; 21(51):7883-90. PubMed ID: 12420225 [Abstract] [Full Text] [Related]